Lundbeck
HLUN-B.CO
#2799
Rank
C$8.36 B
Marketcap
C$8.43
Share price
-2.55%
Change (1 day)
8.81%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): C$0.85

According to Lundbeck's latest financial reports the company's current EPS (TTM) is C$0.84. an increase over its 2024 EPS that were of C$0.61.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025C$0.6914.5%
2024C$0.6129.29%
2023C$0.4723.09%
2022C$0.3837.26%
2021C$0.28-84.61%
2020C$1.80-24.61%
2019C$2.39-42.06%
2018C$4.1240.7%
2017C$2.93146.26%
2016C$1.19-120.48%
2015C-$5.813231.32%
2014C-$0.17-115.78%
2013C$1.11-23.36%
2012C$1.44-48.01%
2011C$2.77-9.68%
2010C$3.0713.72%
2009C$2.7024.32%
2008C$2.17-6.05%
2007C$2.3181.77%
2006C$1.27-16.76%
2005C$1.53-17.58%
2004C$1.85